You are currently viewing a new version of our website. To view the old version click .

Vaccines, Volume 10, Issue 6

June 2022 - 152 articles

Cover Story: Patients from socially deprived and ethnic minority backgrounds associated with increased COVID-19 vaccine hesitancy are over-represented in the renal replacement therapy (RRT) population. A bespoke vaccination programme was designed with the involvement of a multidisciplinary team, using clinical teams as trusted messengers, patient engagement, local safety, and efficacy data to ensure equitable access to this life-saving intervention. The results of the programme showed that the total uptake for a first dose of COVID-19 vaccination was high at 96.7% and there were no statistically significant differences in patients from ethnic minority groups or socially deprived backgrounds. The vaccination uptake was higher compared to the reference regional adult clinically extremely vulnerable population. This work can inform other initiatives to address health inequalities in RRT patients. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (152)

  • Article
  • Open Access
13 Citations
4,285 Views
17 Pages

Anti-Vaccine Attitudes among Adults in the U.S. during the COVID-19 Pandemic after Vaccine Rollout

  • Jasmin Choi,
  • Sarah A. Lieff,
  • Gabriella Y. Meltzer,
  • Margaux M. Grivel,
  • Virginia W. Chang,
  • Lawrence H. Yang and
  • Don C. Des Jarlais

10 June 2022

Even though vaccination is the most effective measure against COVID-19 infections, vaccine rollout efforts have been hampered by growing anti-vaccine attitudes. Based on current knowledge, we identified three domains (beliefs, discrimination, and new...

  • Case Report
  • Open Access
10 Citations
4,136 Views
5 Pages

10 June 2022

People are advised to receive a vaccine booster as the Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerge, but various adverse ocular reactions after vaccination have been reported. NAION following COVID...

  • Review
  • Open Access
10 Citations
2,621 Views
15 Pages

10 June 2022

Background: The uptake of human papillomavirus vaccines (HPVV) among men who have sex with men (MSM) remains unsatisfactory. Healthcare providers play a crucial role in improving HPVV acceptability and uptake among MSM. This scoping review aims to pr...

  • Article
  • Open Access
7 Citations
2,938 Views
14 Pages

Immunological Study of Combined Administration of SARS-CoV-2 DNA Vaccine and Inactivated Vaccine

  • Ziyan Meng,
  • Danjing Ma,
  • Suqin Duan,
  • Jingjing Zhang,
  • Rong Yue,
  • Xinghang Li,
  • Yang Gao,
  • Xueqi Li,
  • Fengyuan Zeng and
  • Xiangxiong Xu
  • + 12 authors

10 June 2022

Objective: We constructed two DNA vaccines containing the receptor-binding domain (RBD) genes of multiple SARS-CoV-2 variants and used them in combination with inactivated vaccines in a variety of different protocols to explore potential novel immuni...

  • Brief Report
  • Open Access
17 Citations
2,421 Views
8 Pages

COVID-19 Concerns, Vaccine Acceptance and Trusted Sources of Information among Patients Cared for in a Safety-Net Health System

  • Terry C. Davis,
  • Robbie Beyl,
  • Mohammad A. N. Bhuiyan,
  • Adrienne B. Davis,
  • John A. Vanchiere,
  • Michael S. Wolf and
  • Connie L. Arnold

10 June 2022

We examined COVID-19 concerns, vaccine acceptance, and trusted sources of information among patients in a safety-net health system in Louisiana. The participants were surveyed via structured telephone interviews over nine months in 2021. Of 204 adult...

  • Article
  • Open Access
6 Citations
3,264 Views
13 Pages

Adenoviral-Vectored Centralized Consensus Hemagglutinin Vaccine Provides Broad Protection against H2 Influenza a Virus

  • Erika M. Petro-Turnquist,
  • Brianna L. Bullard,
  • Matthew J. Pekarek and
  • Eric A. Weaver

10 June 2022

Several influenza pandemics have occurred in the past century, one of which emerged in 1957 from a zoonotic transmission of H2N2 from an avian reservoir into humans. This pandemic caused 2–4 million deaths and circulated until 1968. Since the d...

  • Article
  • Open Access
2 Citations
3,116 Views
17 Pages

10 June 2022

Neospora caninum is an obligate intracellular protozoan responsible for abortion and stillbirths in cattle. We previously developed a mucosal vaccination approach using N. caninum membrane proteins and CpG adjuvant that conferred long-term protection...

  • Article
  • Open Access
25 Citations
5,202 Views
16 Pages

Surveillance of Post-Vaccination Side Effects of COVID-19 Vaccines among Saudi Population: A Real-World Estimation of Safety Profile

  • Abdulaziz Ibrahim Alzarea,
  • Yusra Habib Khan,
  • Ahmed D. Alatawi,
  • Abdullah Salah Alanazi,
  • Sami I. Alzarea,
  • Muhammad Hammad Butt,
  • Ziyad Saeed Almalki,
  • Abdullah K. Alahmari and
  • Tauqeer Hussain Mallhi

10 June 2022

Vaccines are considered to be the most beneficial means for combating the COVID-19 pandemic. Although vaccines against SARS-CoV-2 have demonstrated excellent safety profiles in clinical trials, real-world surveillance of post-vaccination side effects...

  • Case Report
  • Open Access
8 Citations
3,764 Views
9 Pages

IgA vasculitis is an immune complex-mediated small-vessel vasculitis that mainly occurs in children and is characterized by palpable purpura, arthralgia, abdominal pain, and glomerulonephritis. We report three cases of new-onset IgA vasculitis involv...

  • Communication
  • Open Access
24 Citations
4,393 Views
7 Pages

Vaccination against coronavirus disease 2019 (COVID-19) has become an important public health solution. Developing a safe and effective vaccine against COVID-19 is a viable long-term solution to control the pandemic. As one of the two inactivated sev...

of 16

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X